IMMUNOGENICITY
Clinical trials for IMMUNOGENICITY explained in plain language.
Never miss a new study
Get alerted when new IMMUNOGENICITY trials appear
Sign up with your email to follow new studies for IMMUNOGENICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Single-dose HPV vaccine showdown: can CERVAVAC match gardasil?
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests whether one dose of the CERVAVAC HPV vaccine works as well as one dose of the Gardasil vaccine. About 1,266 girls, boys, and young women in Zambia will receive a single shot and have their immune response checked at 6, 12, and 24 months. The goal is to see if CER…
Matched conditions: IMMUNOGENICITY
Phase: PHASE4 • Sponsor: International Agency for Research on Cancer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 12, 2026 12:03 UTC
-
New eye injection PRO-169 under safety spotlight in early trial
Knowledge-focused Not yet recruitingThis early-phase study tests whether a new eye injection called PRO-169 is safe for people with diabetic macular edema, a condition that causes vision loss. Researchers will check if the body makes antibodies against the drug, which could reduce its effectiveness. The study invol…
Matched conditions: IMMUNOGENICITY
Phase: PHASE1 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:29 UTC